eohilia - Medication Listings

Browse 1 medications by eohilia. Open a product record to review strengths, dosage forms, label-backed details, and related navigation.

Eohilia BUDESONIDE
(BUDESONIDE) 2 mg/10 ml Suspension
TAKEDA PHARMACEUTICALS AMERICA, INC. FDA Rx Only

EOHILIA (budesonide oral suspension) contains budesonide, a synthetic corticosteroid. Budesonide is designated chemically as (RS)-11β, 16α, 17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde. Budesonide is a mixture of two epimers (22 R and 22 S ). The empirical formula of budesonide is C 25 H 34 O 6 and its molecular weight is 430.53. Its structural formula is: Budesonide is a white or almost-white, crystalline powder that is freely soluble in chloroform, sparingly soluble in alcohol and practically insoluble in water and heptane. EOHILIA (budesonide oral suspension) is a white to yellow, thixotropic, viscous suspension. Each 10 mL of EOHILIA contains 2 mg of budesonide. The oral suspension contains the following inactive ingredients: acesulfame potassium, ascorbic acid, Avicel ® RC-591, cherry flavor, citric acid, dextrose, disodium ethylenediaminetetraacetic acid (EDTA), glycerin, Magnasweet ® 110, maltodextrin, polysorbate 80, potassium sorbate, sodium ascorbate, sodium benzoate, sodium citrate, and purified water. Excipients contain no ingredient made from a gluten-containing grain (wheat, barley, or rye). Chemical Structure

About eohilia Medications

This collection groups medications in our database that are associated with eohilia. It currently includes 1 matching listing.

How to Use This Page

Use these results to move into a specific drug detail page, then follow related brand, generic, manufacturer, or substance links for broader exploration.

Safety Information

Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. The information provided on this page is for educational purposes only and does not constitute medical advice.

Medical Tools & Resources

← Back to search